IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q1 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,318,000 | +14.1% | 67,759 | -2.3% | 0.02% | +14.3% |
| Q4 2017 | $1,155,000 | +125.6% | 69,373 | +175.3% | 0.01% | +133.3% |
| Q3 2017 | $512,000 | +26.1% | 25,200 | 0.0% | 0.01% | +20.0% |
| Q2 2017 | $406,000 | +27.3% | 25,200 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $319,000 | -4.5% | 25,200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $334,000 | -94.7% | 25,200 | -90.5% | 0.00% | -94.9% |
| Q3 2016 | $6,284,000 | -11.6% | 265,128 | +7.4% | 0.08% | -16.0% |
| Q2 2016 | $7,112,000 | -7.5% | 246,800 | +2.8% | 0.09% | -6.0% |
| Q1 2016 | $7,685,000 | -39.8% | 240,000 | -19.7% | 0.10% | -38.7% |
| Q4 2015 | $12,772,000 | +39.1% | 298,700 | +14.5% | 0.16% | +34.7% |
| Q3 2015 | $9,183,000 | -31.7% | 260,800 | -10.9% | 0.12% | -24.4% |
| Q2 2015 | $13,436,000 | -2.0% | 292,600 | 0.0% | 0.16% | +1.3% |
| Q1 2015 | $13,714,000 | +34.9% | 292,600 | -8.8% | 0.16% | +37.4% |
| Q4 2014 | $10,166,000 | +33.6% | 320,900 | 0.0% | 0.12% | +27.8% |
| Q3 2014 | $7,609,000 | +1.4% | 320,900 | +28.3% | 0.09% | +3.4% |
| Q2 2014 | $7,504,000 | +12.8% | 250,200 | -0.6% | 0.09% | +11.5% |
| Q1 2014 | $6,650,000 | -2.6% | 251,700 | -7.3% | 0.08% | -1.3% |
| Q4 2013 | $6,828,000 | +22.0% | 271,600 | -0.7% | 0.08% | +54.9% |
| Q3 2013 | $5,597,000 | -10.0% | 273,400 | -12.4% | 0.05% | -13.6% |
| Q2 2013 | $6,222,000 | – | 312,100 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |